190 related articles for article (PubMed ID: 36990163)
1. Rifampin monotherapy for children with idiopathic infantile hypercalcemia.
Lenherr-Taube N; Furman M; Assor E; Thummel K; Levine MA; Sochett E
J Steroid Biochem Mol Biol; 2023 Jul; 231():106301. PubMed ID: 36990163
[TBL] [Abstract][Full Text] [Related]
2. CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations.
Hawkes CP; Li D; Hakonarson H; Meyers KE; Thummel KE; Levine MA
J Clin Endocrinol Metab; 2017 May; 102(5):1440-1446. PubMed ID: 28324001
[TBL] [Abstract][Full Text] [Related]
3. Mild Idiopathic Infantile Hypercalcemia-Part 1: Biochemical and Genetic Findings.
Lenherr-Taube N; Young EJ; Furman M; Elia Y; Assor E; Chitayat D; Uster T; Kirwin S; Robbins K; Vinette KMB; Daneman A; Marshall CR; Collins C; Thummel K; Sochett E; Levine MA
J Clin Endocrinol Metab; 2021 Sep; 106(10):2915-2937. PubMed ID: 34125233
[TBL] [Abstract][Full Text] [Related]
4. Long-term Efficacy and Safety of Rifampin in the Treatment of a Patient Carrying a CYP24A1 Loss-of-Function Variant.
Brancatella A; Cappellani D; Kaufmann M; Semeraro A; Borsari S; Sardella C; Baldinotti F; Caligo MA; Jones G; Marcocci C; Cetani F
J Clin Endocrinol Metab; 2022 Jul; 107(8):e3159-e3166. PubMed ID: 35569070
[TBL] [Abstract][Full Text] [Related]
5. Mild Idiopathic Infantile Hypercalcemia-Part 2: A Longitudinal Observational Study.
Lenherr-Taube N; Furman M; Assor E; Elia Y; Collins C; Thummel K; Levine MA; Sochett E
J Clin Endocrinol Metab; 2021 Sep; 106(10):2938-2948. PubMed ID: 34139759
[TBL] [Abstract][Full Text] [Related]
6. CYP24A1 loss of function: Clinical phenotype of monoallelic and biallelic mutations.
Carpenter TO
J Steroid Biochem Mol Biol; 2017 Oct; 173():337-340. PubMed ID: 28093352
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic infantile hypercalcemia in children with chronic kidney disease due to kidney hypodysplasia.
Gurevich E; Borovitz Y; Levi S; Perlman S; Landau D
Pediatr Nephrol; 2023 Apr; 38(4):1067-1073. PubMed ID: 36156733
[TBL] [Abstract][Full Text] [Related]
8. Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH cases.
Pronicka E; Ciara E; Halat P; Janiec A; Wójcik M; Rowińska E; Rokicki D; Płudowski P; Wojciechowska E; Wierzbicka A; Książyk JB; Jacoszek A; Konrad M; Schlingmann KP; Litwin M
J Appl Genet; 2017 Aug; 58(3):349-353. PubMed ID: 28470390
[TBL] [Abstract][Full Text] [Related]
9. Analysis of vitamin D
Kowalska E; Rola R; Wójcik M; Łaszcz N; Płudowski P; Wierzbicka A; Janiec A; Książyk J; Halat P; Ciara E; Obrycki Ł; Pronicka E; Litwin M
J Steroid Biochem Mol Biol; 2021 Apr; 208():105824. PubMed ID: 33516786
[TBL] [Abstract][Full Text] [Related]
10. Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations.
Figueres ML; Linglart A; Bienaime F; Allain-Launay E; Roussey-Kessler G; Ryckewaert A; Kottler ML; Hourmant M
Am J Kidney Dis; 2015 Jan; 65(1):122-6. PubMed ID: 25446019
[TBL] [Abstract][Full Text] [Related]
11. Biallelic and monoallelic pathogenic variants in CYP24A1 and SLC34A1 genes cause idiopathic infantile hypercalcemia.
Wang Q; Chen JJ; Wei LY; Ding Y; Liu M; Li WJ; Su C; Gong CX
Orphanet J Rare Dis; 2024 Mar; 19(1):126. PubMed ID: 38504242
[TBL] [Abstract][Full Text] [Related]
12. When to suspect infantile hypercalcemia-1?
Brancatella A; Cappellani D; Pierotti L; Dinoi E; Sardella C; Borsari S; Piaggi P; Baldinotti F; Caligo MA; Marcocci C; Cetani F
J Endocrinol Invest; 2024 Feb; ():. PubMed ID: 38329607
[TBL] [Abstract][Full Text] [Related]
13. Gestational hypercalcemia: Prevalence and biochemical profile.
Schoenmakers I; Piec I; Baban S; Bärebring L; Green D; Washbourne CJ; Tang JCY; Fraser WD; Augustin H
J Steroid Biochem Mol Biol; 2020 May; 199():105611. PubMed ID: 32007562
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.
Tebben PJ; Singh RJ; Kumar R
Endocr Rev; 2016 Oct; 37(5):521-547. PubMed ID: 27588937
[TBL] [Abstract][Full Text] [Related]
15. Calcium and bone homeostasis in heterozygous carriers of CYP24A1 mutations: A cross-sectional study.
Cools M; Goemaere S; Baetens D; Raes A; Desloovere A; Kaufman JM; De Schepper J; Jans I; Vanderschueren D; Billen J; De Baere E; Fiers T; Bouillon R
Bone; 2015 Dec; 81():89-96. PubMed ID: 26117226
[TBL] [Abstract][Full Text] [Related]
16. Improved Screening Test for Idiopathic Infantile Hypercalcemia Confirms Residual Levels of Serum 24,25-(OH)
Kaufmann M; Morse N; Molloy BJ; Cooper DP; Schlingmann KP; Molin A; Kottler ML; Gallagher JC; Armas L; Jones G
J Bone Miner Res; 2017 Jul; 32(7):1589-1596. PubMed ID: 28304097
[TBL] [Abstract][Full Text] [Related]
17. Overlapping Phenotypes Associated With
Molin A; Lemoine S; Kaufmann M; Breton P; Nowoczyn M; Ballandonne C; Coudray N; Mittre H; Richard N; Ryckwaert A; Lavillaureix A; Jones G; Bacchetta J; Kottler ML
Front Endocrinol (Lausanne); 2021; 12():736240. PubMed ID: 34721296
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic infantile hypercalcemia: mutations in SLC34A1 and CYP24A1 in two siblings and fathers.
Güven A; Konrad M; Schlingmann KP
J Pediatr Endocrinol Metab; 2020 Aug; 33(10):1353-1358. PubMed ID: 32866123
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D and Diseases of Mineral Homeostasis: A
St-Arnaud R; Arabian A; Kavame D; Kaufmann M; Jones G
Nutrients; 2022 Aug; 14(15):. PubMed ID: 35956396
[TBL] [Abstract][Full Text] [Related]
20. CYP24A1 and SLC34A1 Pathogenic Variants Are Uncommon in a Canadian Cohort of Children with Hypercalcemia or Hypercalciuria.
Rousseau-Nepton I; Jones G; Schlingmann K; Kaufmann M; Zuijdwijk CS; Khatchadourian K; Gupta IR; Pacaud D; Pinsk MN; Mokashi A; Nour MA; Alexander RT; Rodd CJ
Horm Res Paediatr; 2021; 94(3-4):124-132. PubMed ID: 34320495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]